Home › Funds › Viking Global Investors › ROIV
Viking Global Investors position in ROIV
ROIVANT SCIENCES LTD · Health Care
Latest position (Q2 2026)6.27M sh
Reported value held$221.95M
Portfolio Weight0.64%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 88.24M | $889.45M | New |
| Q1 2022 | 88.24M | $435.90M | Hold |
| Q2 2022 | 88.24M | $359.13M | Hold |
| Q3 2022 | 88.24M | $284.13M | Hold |
| Q4 2022 | 88.24M | $705.03M | Hold |
| Q1 2023 | 88.24M | $651.20M | Hold |
| Q2 2023 | 75.24M | $758.41M | Reduce |
| Q3 2023 | 73.43M | $857.71M | Reduce |
| Q4 2023 | 69.37M | $779.01M | Reduce |
| Q1 2024 | 69.37M | $731.15M | Hold |
| Q2 2024 | 69.16M | $730.98M | Hold |
| Q3 2024 | 54.10M | $624.30M | Reduce |
| Q4 2024 | 47.81M | $565.59M | Reduce |
| Q1 2025 | 46.01M | $464.28M | Reduce |
| Q2 2025 | 34.24M | $385.86M | Reduce |
| Q3 2025 | 23.59M | $356.99M | Reduce |
| Q4 2025 | 6.44M | $139.82M | Reduce |
| Q1 2026 | 6.65M | $184.27M | Add |
| Q2 2026 | 6.27M | $221.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ROIV
- Fidelity Management & Research (FMR) 81.02M sh · $2.87B · Q2 2026
- BlackRock Inc 48.24M sh · $1.71B · Q2 2026
- Morgan Stanley 42.59M sh · $1.51B · Q2 2026
- Vanguard Group 42.06M sh · $912.68M · Q4 2025
- Goldman Sachs Group 18.56M sh · $656.71M · Q2 2026
- UBS Group AG 17.47M sh · $618.14M · Q2 2026
- Farallon Capital Management 14.31M sh · $506.40M · Q2 2026
- Geode Capital Management 11.67M sh · $425.54M · Q2 2026
- Wells Fargo & Co 9.72M sh · $344.04M · Q2 2026
- Invesco Ltd 7.53M sh · $266.53M · Q2 2026
- AQR Capital Management 6.63M sh · $234.03M · Q2 2026